UniProt ID | NDC1_HUMAN | |
---|---|---|
UniProt AC | Q9BTX1 | |
Protein Name | Nucleoporin NDC1 | |
Gene Name | NDC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 674 | |
Subcellular Localization |
Nucleus, nuclear pore complex. Nucleus membrane Multi-pass membrane protein. Central core structure of the nuclear pore complex. |
|
Protein Description | Component of the nuclear pore complex (NPC), which plays a key role in de novo assembly and insertion of NPC in the nuclear envelope. Required for NPC and nuclear envelope assembly, possibly by forming a link between the nuclear envelope membrane and soluble nucleoporins, thereby anchoring the NPC in the membrane.. | |
Protein Sequence | MATAVSRPCAGRSRDILWRVLGWRIVASIVWSVLFLPICTTVFIIFSRIDLFHPIQWLSDSFSDLYSSYVIFYFLLLSVVIIIISIFNVEFYAVVPSIPCSRLALIGKIIHPQQLMHSFIHAAMGMVMAWCAAVITQGQYSFLVVPCTGTNSFGSPAAQTCLNEYHLFFLLTGAFMGYSYSLLYFVNNMNYLPFPIIQQYKFLRFRRSLLLLVKHSCVESLFLVRNFCILYYFLGYIPKAWISTAMNLHIDEQVHRPLDTVSGLLNLSLLYHVWLCGVFLLTTWYVSWILFKIYATEAHVFPVQPPFAEGSDECLPKVLNSNPPPIIKYLALQDLMLLSQYSPSRRQEVFSLSQPGGHPHNWTAISRECLNLLNGMTQKLILYQEAAATNGRVSSSYPVEPKKLNSPEETAFQTPKSSQMPRPSVPPLVKTSLFSSKLSTPDVVSPFGTPFGSSVMNRMAGIFDVNTCYGSPQSPQLIRRGPRLWTSASDQQMTEFSNPSPSTSISAEGKTMRQPSVIYSWIQNKREQIKNFLSKRVLIMYFFSKHPEASIQAVFSDAQMHIWALEGLSHLVAASFTEDRFGVVQTTLPAILNTLLTLQEAVDKYFKLPHASSKPPRISGSLVDTSYKTLRFAFRASLKTAIYRITTTFGEHLNAVQASAEHQKRLQQFLEFKE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
339 | Ubiquitination | LQDLMLLSQYSPSRR HHHHHHHHCCCHHHH | 24.10 | 21963094 | |
342 | Phosphorylation | LMLLSQYSPSRRQEV HHHHHCCCHHHHHEE | 14.57 | 28348404 | |
344 | Phosphorylation | LLSQYSPSRRQEVFS HHHCCCHHHHHEEEE | 33.87 | - | |
362 | Ubiquitination | PGGHPHNWTAISREC CCCCCCCHHHHHHHH | 5.56 | 33845483 | |
363 | Ubiquitination | GGHPHNWTAISRECL CCCCCCHHHHHHHHH | 21.30 | 21963094 | |
366 | Phosphorylation | PHNWTAISRECLNLL CCCHHHHHHHHHHHH | 21.40 | 32645325 | |
376 | Ubiquitination | CLNLLNGMTQKLILY HHHHHCCHHHHHHHH | 3.31 | 33845483 | |
378 | Ubiquitination | NLLNGMTQKLILYQE HHHCCHHHHHHHHHH | 29.66 | 21963094 | |
379 | Ubiquitination | LLNGMTQKLILYQEA HHCCHHHHHHHHHHH | 28.47 | 21963094 | |
390 | Ubiquitination | YQEAAATNGRVSSSY HHHHHHHCCCCCCCC | 31.39 | 23000965 | |
394 | Phosphorylation | AATNGRVSSSYPVEP HHHCCCCCCCCCCCC | 16.53 | 19691289 | |
395 | Phosphorylation | ATNGRVSSSYPVEPK HHCCCCCCCCCCCCC | 30.91 | 19691289 | |
396 | Phosphorylation | TNGRVSSSYPVEPKK HCCCCCCCCCCCCCC | 26.42 | 19691289 | |
397 | Phosphorylation | NGRVSSSYPVEPKKL CCCCCCCCCCCCCCC | 17.16 | 28152594 | |
397 | Ubiquitination | NGRVSSSYPVEPKKL CCCCCCCCCCCCCCC | 17.16 | 21963094 | |
401 | Ubiquitination | SSSYPVEPKKLNSPE CCCCCCCCCCCCCCH | 39.04 | 22817900 | |
402 (in isoform 2) | Ubiquitination | - | 57.28 | 21890473 | |
402 | Ubiquitination | SSYPVEPKKLNSPEE CCCCCCCCCCCCCHH | 57.28 | 21963094 | |
403 (in isoform 1) | Ubiquitination | - | 64.71 | 21890473 | |
403 (in isoform 4) | Ubiquitination | - | 64.71 | 21890473 | |
403 | Ubiquitination | SYPVEPKKLNSPEET CCCCCCCCCCCCHHH | 64.71 | 21906983 | |
406 | Phosphorylation | VEPKKLNSPEETAFQ CCCCCCCCCHHHCCC | 44.09 | 19664994 | |
410 | Phosphorylation | KLNSPEETAFQTPKS CCCCCHHHCCCCCCH | 30.98 | 30266825 | |
414 | Phosphorylation | PEETAFQTPKSSQMP CHHHCCCCCCHHCCC | 26.65 | 29255136 | |
415 | Ubiquitination | EETAFQTPKSSQMPR HHHCCCCCCHHCCCC | 24.61 | 27667366 | |
416 | Ubiquitination | ETAFQTPKSSQMPRP HHCCCCCCHHCCCCC | 67.15 | 33845483 | |
417 | Phosphorylation | TAFQTPKSSQMPRPS HCCCCCCHHCCCCCC | 27.32 | 25159151 | |
418 | Phosphorylation | AFQTPKSSQMPRPSV CCCCCCHHCCCCCCC | 36.30 | 25159151 | |
424 | Phosphorylation | SSQMPRPSVPPLVKT HHCCCCCCCCCCCCH | 48.84 | 25159151 | |
429 | Ubiquitination | RPSVPPLVKTSLFSS CCCCCCCCCHHHHCC | 8.62 | 21890473 | |
429 (in isoform 2) | Ubiquitination | - | 8.62 | 21890473 | |
429 | Ubiquitination | RPSVPPLVKTSLFSS CCCCCCCCCHHHHCC | 8.62 | 21890473 | |
430 (in isoform 1) | Ubiquitination | - | 39.83 | 21890473 | |
430 (in isoform 4) | Ubiquitination | - | 39.83 | 21890473 | |
430 | Ubiquitination | PSVPPLVKTSLFSSK CCCCCCCCHHHHCCC | 39.83 | 23000965 | |
431 | Phosphorylation | SVPPLVKTSLFSSKL CCCCCCCHHHHCCCC | 24.15 | 28122231 | |
432 | Phosphorylation | VPPLVKTSLFSSKLS CCCCCCHHHHCCCCC | 23.00 | 21815630 | |
435 | Phosphorylation | LVKTSLFSSKLSTPD CCCHHHHCCCCCCCC | 31.68 | 21815630 | |
436 (in isoform 2) | Ubiquitination | - | 30.22 | 21890473 | |
436 | Phosphorylation | VKTSLFSSKLSTPDV CCHHHHCCCCCCCCC | 30.22 | 17192257 | |
436 | Ubiquitination | VKTSLFSSKLSTPDV CCHHHHCCCCCCCCC | 30.22 | 21963094 | |
436 | Ubiquitination | VKTSLFSSKLSTPDV CCHHHHCCCCCCCCC | 30.22 | 21890473 | |
437 (in isoform 1) | Ubiquitination | - | 45.30 | 21890473 | |
437 | Ubiquitination | KTSLFSSKLSTPDVV CHHHHCCCCCCCCCC | 45.30 | 21963094 | |
437 (in isoform 4) | Ubiquitination | - | 45.30 | 21890473 | |
439 | Phosphorylation | SLFSSKLSTPDVVSP HHHCCCCCCCCCCCC | 41.45 | 22617229 | |
440 | Phosphorylation | LFSSKLSTPDVVSPF HHCCCCCCCCCCCCC | 33.66 | 26055452 | |
445 | Phosphorylation | LSTPDVVSPFGTPFG CCCCCCCCCCCCCCC | 17.85 | 26055452 | |
449 | Phosphorylation | DVVSPFGTPFGSSVM CCCCCCCCCCCHHHH | 18.80 | 26055452 | |
453 | Phosphorylation | PFGTPFGSSVMNRMA CCCCCCCHHHHHHHC | 21.82 | 25850435 | |
454 | Phosphorylation | FGTPFGSSVMNRMAG CCCCCCHHHHHHHCC | 26.26 | 25850435 | |
467 | Phosphorylation | AGIFDVNTCYGSPQS CCCCCCCCCCCCCCC | 13.62 | 23663014 | |
469 | Phosphorylation | IFDVNTCYGSPQSPQ CCCCCCCCCCCCCHH | 20.71 | 29255136 | |
470 | Ubiquitination | FDVNTCYGSPQSPQL CCCCCCCCCCCCHHH | 34.69 | 21963094 | |
471 | Phosphorylation | DVNTCYGSPQSPQLI CCCCCCCCCCCHHHH | 8.03 | 29255136 | |
474 | Phosphorylation | TCYGSPQSPQLIRRG CCCCCCCCHHHHHCC | 20.28 | 29255136 | |
486 | Phosphorylation | RRGPRLWTSASDQQM HCCCCCEECCCHHCC | 21.00 | 22199227 | |
487 | Phosphorylation | RGPRLWTSASDQQMT CCCCCEECCCHHCCC | 17.75 | 22199227 | |
489 | Phosphorylation | PRLWTSASDQQMTEF CCCEECCCHHCCCCC | 35.40 | 22199227 | |
490 | Ubiquitination | RLWTSASDQQMTEFS CCEECCCHHCCCCCC | 42.31 | 29967540 | |
494 | Phosphorylation | SASDQQMTEFSNPSP CCCHHCCCCCCCCCC | 29.55 | 22199227 | |
495 | Ubiquitination | ASDQQMTEFSNPSPS CCHHCCCCCCCCCCC | 41.56 | 24816145 | |
497 | Phosphorylation | DQQMTEFSNPSPSTS HHCCCCCCCCCCCCC | 41.41 | 25159151 | |
500 | Phosphorylation | MTEFSNPSPSTSISA CCCCCCCCCCCCCCC | 35.42 | 25159151 | |
502 | Phosphorylation | EFSNPSPSTSISAEG CCCCCCCCCCCCCCC | 38.84 | 30278072 | |
503 | Phosphorylation | FSNPSPSTSISAEGK CCCCCCCCCCCCCCC | 33.20 | 30278072 | |
504 | Phosphorylation | SNPSPSTSISAEGKT CCCCCCCCCCCCCCC | 20.91 | 25159151 | |
506 | Phosphorylation | PSPSTSISAEGKTMR CCCCCCCCCCCCCCC | 21.75 | 22199227 | |
509 (in isoform 2) | Ubiquitination | - | 30.37 | 21890473 | |
509 | Ubiquitination | STSISAEGKTMRQPS CCCCCCCCCCCCCCH | 30.37 | 21963094 | |
510 (in isoform 1) | Ubiquitination | - | 30.56 | 21890473 | |
510 | Ubiquitination | TSISAEGKTMRQPSV CCCCCCCCCCCCCHH | 30.56 | 21906983 | |
511 | Phosphorylation | SISAEGKTMRQPSVI CCCCCCCCCCCCHHH | 28.57 | - | |
511 (in isoform 3) | Ubiquitination | - | 28.57 | 21890473 | |
530 | Ubiquitination | QNKREQIKNFLSKRV HCHHHHHHHHHHHHH | 41.14 | 29967540 | |
534 | Ubiquitination | EQIKNFLSKRVLIMY HHHHHHHHHHHHHHH | 17.80 | 24816145 | |
535 | Ubiquitination | QIKNFLSKRVLIMYF HHHHHHHHHHHHHHH | 48.99 | 24816145 | |
541 | Phosphorylation | SKRVLIMYFFSKHPE HHHHHHHHHHHCCHH | 8.42 | 23909892 | |
544 | Phosphorylation | VLIMYFFSKHPEASI HHHHHHHHCCHHHHH | 21.84 | 23909892 | |
588 | Ubiquitination | FGVVQTTLPAILNTL CCCHHHHHHHHHHHH | 2.83 | 21890473 | |
588 | Ubiquitination | FGVVQTTLPAILNTL CCCHHHHHHHHHHHH | 2.83 | 21890473 | |
619 | O-linked_Glycosylation | SSKPPRISGSLVDTS CCCCCCCCCCEECCC | 24.49 | 28411811 | |
621 | Phosphorylation | KPPRISGSLVDTSYK CCCCCCCCEECCCHH | 20.59 | 25247763 | |
624 | Ubiquitination | RISGSLVDTSYKTLR CCCCCEECCCHHHHH | 34.92 | 29967540 | |
625 | Phosphorylation | ISGSLVDTSYKTLRF CCCCEECCCHHHHHH | 26.86 | 21815630 | |
627 | Ubiquitination | GSLVDTSYKTLRFAF CCEECCCHHHHHHHH | 15.30 | 21890473 | |
627 (in isoform 2) | Ubiquitination | - | 15.30 | 21890473 | |
627 | Ubiquitination | GSLVDTSYKTLRFAF CCEECCCHHHHHHHH | 15.30 | 21890473 | |
628 (in isoform 1) | Ubiquitination | - | 40.63 | 21890473 | |
628 | Ubiquitination | SLVDTSYKTLRFAFR CEECCCHHHHHHHHH | 40.63 | 22817900 | |
633 | Ubiquitination | SYKTLRFAFRASLKT CHHHHHHHHHHHHHH | 6.13 | 21963094 | |
664 | Ubiquitination | QASAEHQKRLQQFLE HHHHHHHHHHHHHHH | 57.91 | 29967540 | |
672 | Ubiquitination | RLQQFLEFKE----- HHHHHHHHCC----- | 13.49 | 21963094 | |
673 | Ubiquitination | LQQFLEFKE------ HHHHHHHCC------ | 53.81 | 21963094 | |
673 | 2-Hydroxyisobutyrylation | LQQFLEFKE------ HHHHHHHCC------ | 53.81 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NDC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NDC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NDC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of NDC1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406; THR-410; THR-414;SER-439; THR-440; SER-445; THR-449; SER-471 AND SER-474, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406; THR-414; SER-471AND SER-474, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-471, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406 AND THR-414, ANDMASS SPECTROMETRY. |